This inventor holds 42 USPTO granted patents and 13 published patent applications and 5 EPO patents, primarily in Cancer Immunology. Top assignees: Harvard College, Cornell University, Dana-Farber-Cancer Institute Inc.. Active years: 1997-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- W. Newton, MA (US) (1997)
- West Newton, MA (US) (1999 - 2013)
- Newton, MA (US) (2014)
- New York, NY (US) (2015 - 2020)
- Boston, MA (US) (2019 - 2021)
Company Filing History:
26 out of 3,075 
12 out of 2,953 
6 out of 1,268 
Years Active: 1997-2026
Areas of Expertise:
Title: Laurie H Glimcher: Pioneering Innovations in Medicine
Introduction:
Laurie H Glimcher, the former Dean of Weill Cornell Medicine (2012-2017), is a prominent figure in the field of medicine and biomedical research. As the first female dean of Weill Cornell Medicine, Glimcher made significant contributions to the advancement of medical innovations. With an impressive portfolio of 39 patents, Glimcher's research focuses on small molecule inhibitors and modulation of XBP1 activity in breast cancer. This article will delve into her latest patents, career highlights, notable collaborations, and their impact on medical advancements.
Latest Patents:
Glimcher's recent patents highlight her groundbreaking work in the field of medical research. One of her notable inventions involves small molecule IRE1-α inhibitors. Through this patent, Glimcher has developed innovative compounds that show promise in treating various diseases and conditions. Additionally, she has made significant contributions to the understanding of triple-negative breast cancer (TNBC) by uncovering the role of XBP1 in the growth of TNBC tumors. Her findings suggest that modulation of XBP1 activity can potentially block TNBC tumor growth and inhibit the self-renewal of breast tumor initiating cells.
Career Highlights:
Before serving as the Dean of Weill Cornell Medicine, Glimcher held impressive positions at Harvard College and Cornell University. Her career is characterized by groundbreaking contributions to the field of medicine, pushing the boundaries of scientific knowledge. Glimcher's patent portfolio demonstrates her commitment to translating scientific discoveries into practical applications that can benefit patients worldwide. Her relentless pursuit of innovative solutions has earned her a distinguished reputation among her peers.
Collaborations:
Throughout her career, Glimcher has actively collaborated with esteemed colleagues, propelling advancements in medical research. Notable collaborators include Suzanne Ostrand-Rosenberg and Gordon James Freeman. By working with scientists from diverse backgrounds, Glimcher has fostered interdisciplinary approaches to solving complex medical problems. Collaborations have played a vital role in Glimcher's career, enabling her to tackle challenges collectively and explore innovative strategies in her research.
Conclusion:
Laurie H Glimcher's remarkable career as the Dean of Weill Cornell Medicine has paved the way for transformative medical innovations. Her expertise in small molecule inhibitors and XBP1 modulation has opened new doors for potential treatments in various diseases, particularly in the context of breast cancer. Glimcher's dedication to translating scientific discoveries into patentable inventions showcases her commitment to improving patient outcomes. By collaborating with fellow researchers, she has created a vibrant network of interdisciplinary knowledge exchange that has fueled her groundbreaking work. The remarkable legacy left by Laurie H Glimcher serves as an inspiration for aspiring innovators in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile